ANTI-Ro/SSA 52 ANTIBODIES IN AUTOIMMUNE DISEASES Coordinator: Monica Copotoiu MD,PhD First author: Gabriela Mihai Coauthors: Isabela Micu, Mihaela Budianu,

Slides:

Advertisements

Similar presentations

Advanced Diagnostics Laboratory AUTOANTIBODY OF THE MONTH Case history: A 24 year old woman is seen by her physician complaining of severe fatigue, joint.

Advertisements

Efficacy of Methotrexate and/or Etanercept for treatment of RA Rheumatoid Arthritis:

. The American Autoimmune Related Diseases Association (AARDA) is dedicated to the eradication of autoimmune diseases and the alleviation of the suffering.

Patients with Rheumatoid Arthritis in Comparison to Other Connective Tissue Diseases Are Mostly Influenced by Concomitant Fibromyalgia Tomš J, Daňková.

ANA Testing Carrie Marshall 1/18/08.

Immune Complex Nephritis.

Anti-nuclear antibodies

Autoimmune Diseases Dr. Raid Jastania. Autoimmune Diseases Group of diseases with common pathological process Presence of auto-antibody ?defect in B-cells.

Value of inflammatory markers Useful for diagnosis of inflammatory vs non inflammatory conditions Remember NON-SPECIFIC, increased in infection, inflammation,

The Kidney in Autoimmune Diseases Renal involvement in primary Sjogren’s syndrome Eva Honsová Institute for Clinical and Experimental Medicine Prague,

Immunity and Diseases Scientific background to autoimmune diseases

DIAGNOSIS of AUTOIMMUNE DISEASES Assos. Prof. Gülderen Yanıkkaya Demirel MD, PhD Yeditepe University School of Medicine Immunology Department, Medical.

Department of Pathology

Dr Shoaib Raza.   Immune reactions against self antigens  Affects 1% to 2% of US population  Requirements for an autoimmune disorder:  Presence of.

Lecture 22 Autoimmunity.

This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.

Anti-Nuclear Antibody Tests

Laboratory Tests in Rheumatology

Comorbidity in SLE Compared with Rheumatoid Arthritis and Non-inflammatory Disorders Frederick Wolfe 1, Kaleb Michaud 1,2, Tracy Li 3, Robert S. Katz 4.

AUTOANTIBODIES IN RHEUMATOLOGY G. Cooke VTS Trainee.

Disorders associated with a positive test for Rheumatoid Factor

Sjogren’s SS-A and SS-B antigens Robert Fox, MD Scripps Memorial-Ximed La Jolla, CA.

Autoimmunity and WoMen Kaveri Gurav Infectious Minds Discussion November 17, 2011.

Lecture 8 immunology Autoimmunity Dr. Dalia Galal.

History of ANA testing The LE cells In vitro damaged white cells are coated with “LE Factor” LE factor: a family of antibodies to nuclear constituents.

EPIDEMIOLOGICAL AND CLINICAL FEATURES OF LIVER CIRRHOSIS

Interferences between depression and life quality on patients suffering of type 2 diabetes First Author : Madalina Crisan Coauthors: Madalina Salagean.

Author: Cumurciuc Mihai Co-author:Silvia Ioana Morar Coordinator: Dr. Parvu Mirela.

1 Dr. Amel Eassawi Dr. Abdelrahman Mustafa. HMIM 224 L3: AUTOTOLERANCE 2.

Unit 8: Immune & Lymphatic System 4d. Examine various conditions that change normal body functions (e.g. tissue rejection, allergies, injury, diseases.

CLINICAL AND EPIDEMIOLOGICAL ASPECTS OF LIVER CIRRHOSIS AMONG THE YOUNG AND MIDDLE-AGED PATIENTS FIRST AUTHOR: DOLGHII XENIA COAUTHOR(S) : BORDIANU ALEXANDRA,

AIM OF THIS PRESENTATION  Introduce the important components of the Autoimmune Diseases.  Demonstrate what happens when things go wrong & the body turns.

AUTHOR: MORAR ANICUȚA IONELA COORDINATOR: COPOTOIU MONICA COAUTHOR: ROMAN NICOLETA GRANCEA IULIA.

Rheumatology Review. How to Approach Arthritis DURATION ACUTECHRONIC INFLAMMATION? YESNO Crystal Deposition Infection Early Chronic Trauma Hemarthrosis.

Prognostic factors in systemic lupus erithematosus Author: Nicoleta Roman Cooauthor: Anicua-Ionela Morar Coordinator: Lecturer Dr. Monica Copotoiu U.M.F.

AUTHOR: MORAR ANICUȚA IONELA COAUTHOR: ROMAN NICOLETA GRANCEA IULIA COORDINATOR: COPOTOIU MONICA.

EQ-5D and SF-36 Quality of Life Measures in Systemic Lupus Erythematosus: Comparisons with RA, Non-Inflammatory Disorders (NIRD), and Fibromyalgia (FM)

Undifferentiated Connective Tissue Disease (What is the relationship between UCTD and SLE?) R. John Looney, MD Stephen and Elise Rosenfeld Distinguished.

Mixed Connective Tissue Disease

R HEUMATOID F ACTOR ( RF ). Rheumatoid arthritis is a chronic inflammatory disorder that affects all joints either in hands or feet and other areas of.

AUTOIMMUNITY. Autoimmunity Breaking of self tolerance Both B and T cells may be involved (however, most are antibody mediated)

RHEUMATOID ARTHRITIS (RA)

RHEUMATOID ARTHRITIS (RA). Introduction RA is a chronic, systemic inflammatory disorder of unknown etiology characterized by the manner in which it involved.

Autoantibodies associated with Rheumatic disease

Recommendation 1: Defining & Diagnosing UPIA. Learning Objectives State the definition of Undifferentiated Peripheral Inflammatory Arthritis (UPIA) Describe.

2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative An.

RHEUMATOLOGY TESTING Maureen Sestito, D.O. PCOM Internal Medicine Residency.

The ELISA Test What is it used for? How does it work?

4. Rheumatologic conditions

From: Prevalence of Antineutrophil Cytoplasmic Antibodies in a Large Inception Cohort of Patients with Connective Tissue Disease Ann Intern Med. 1997;126(11):

© The Author(s) Published by Science and Education Publishing.

“Mixed Connective Tissue Disease: Still Crazy After All These Years”

3. AUTOIMMUNITY Immune Mechanisms Tolerance 4. Rheumatologic diseases

Vrushali Patwardhan, Dinesh Kumar, Varun Goel, Sarman Singh

Autoimmune diseases Ali Al Khader, M.D. Faculty of Medicine

Figure 1 Historical evolution of the clinical classification and

Figure 2 A timeline summarizing the development of diagnostic tools in rheumatology Figure 2 | A timeline summarizing the development of diagnostic tools.

Kaplan–Meier survival curves of interstitial pneumonia with autoimmune features (IPAF) with usual interstitial pneumonia (UIP) pattern (on high-resolution.

Figure 3 Transcriptome studies performed in the target

Figure 2 Shared genetic loci in systemic autoimmune diseases

(A) Proposed new ANA result interpretation algorithm that includes the anti-DFS70 results. (A) Proposed new ANA result interpretation algorithm that includes.

Volume 147, Issue 2, Pages (August 2014)

Nat. Rev. Rheumatol. doi: /nrrheum

Autoimmune diseases Ali Al Khader, M.D. Faculty of Medicine

Jack C. O’Brien, Benjamin F. Chong

Phosphorylation levels of discoidin domain receptor (DDR)2.

Jack C. O’Brien, Benjamin F. Chong

Systemic autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and systemic sclerosis (SSc) cause immune-mediated.

Anti-CarALB antibody prevalence and levels in RA and other CTD

Presentation transcript:

ANTI-Ro/SSA 52 ANTIBODIES IN AUTOIMMUNE DISEASES Coordinator: Monica Copotoiu MD,PhD First author: Gabriela Mihai Coauthors: Isabela Micu, Mihaela Budianu, Andrea Lőrincz

Defining criteria for autoimmune diseases Witebsky's postulates ˡ : 1.An autoimmune reaction is identified in the form of autoantibody or cell-mediated immune reaction 2.The corresponding antigen is known 3. An analogous response causes a similar disease in experimental animals ˡ Rose, N. R., C. Bona Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol. Today

Anti-Ro/SSA 52 antibodies(aSSA52) aSSA52 are one of the most frequently detected antibodies against Extractable Nuclear Antigen(ENA) ˡ Clinically,the presence of aSSA52 has been reported in various rheumatic diseases but also in other autoimmune diseases. ˡ Ryusule Yoshimi et al. Clinical and Pathological Roles of Ro/SSA Autoantibody System. Clinical and Developmental Immunology Volume

aSSA52 and Autoimmune diseases association aSSA52 and AD association according to the literature ˡ Polymyositis/Dermatomyositis (PM/DM) Systemic Lupus Erythematosus (SLE) Sjogren syndrome (SjS) Undifferentiated connective tissue disease (UCTD) Systemic Sclerosis (SSc) Rheumatoid Arthritis (RA) Neonatal Lupus Erythematosus (NLE) Primary biliary cirrhosis (PBC) Autoimmune Hepatitis I (AIH I) ˡDefendenti C et al. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.Autoimmune Rev 2011 Jan

aSSA52 detection.Extractable Nuclear Antigen (ENA) panel Anti-Rnp/SmAnti-Cenp B Anti-SmAnti-PCNA Anti-SSA(Ro)Anti-DsDNA Anti-SSA-Ro52 Anti-Nucleosome Anti-SSB(La)Anti-Histone Anti-Scl-70Anti Ribosomal P protein Anti-PM-SclAnti AMA-M2 Anti-Jo-1

Objective Our purpose is to study the clinical significance and immunological association in patients displaying aSSA52 in various autoimmune diseases(AD).

Material and Method single center Mureș County Emergency Clinical Hospital,Rheumatology Division retrospective and prospective( ) 41 patients ENA immunoblotting panels analysis

Material and method Autoimmune Disease (AD) was defined when a patient displayed one of these: 1.Systemic Lupus Erythematosus(SLE) 2.Polymyositis/Dermatomyositis(PM/DM) 3.Sjogren Syndrome(SjS) 4.Rheumatoid Arthritis(RA) 5.Systemic Sclerosis(SSc ) 6.Unedifferentiated Connective tissue disease(UCTD)

Material and method Inclusion criteriaExclusion criteria

Results

Gender distribution through connective tissue diseases(CTD)

Gender distribution

Mean age of onset of CTDs between aSSA52- and aSSA52+ groups

Distribution of aSSA52 through CTDs P value=0.058

Extractable nuclear antigen (ENA) antibodies distribution

aSSA52 associated auto-antibodies (p-0.01) (p-0.03)

Interstitial pulmonary fibrosis (IFP) prevalence in positive and negative aSSA52 groups 12.2 % 7.3 % 58.5% 22% P (ns)

Distribution of IPF through Connective tissue diseases (CTDs) in aSSA52+ group

Clinical manifestations in CTDs and aSSA52

Study limitations In our study, only a few patients had inclusion criteria (n=41) and the small sample size limits the power of the study. Differences between aSSA52+ and aSSA52- groups regarding CTDs features were not significant perhaps due to low absolute numbers which limit the statistical analysis.

Conclusions It seems that the presence of aSSA52 are associated with IPF in CTDs. The most prevalent autoimmune diseases associating aSSA52 are PM and SLE. It is recommended to monitor aSSA52 in patiens diagnosed with CTDs in order to predict the outcome.